Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FX2AB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,993
Award facts
- Contract value 100% obligated
- $20,993.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for ALYFTREK 10-50-125 mg tablets in quantities of 14 units. This $20,993.31 firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation. The order was placed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at $499.999 billion and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities nationwide.
DMS Pharmaceutical Group leverages its status as a woman-owned small business to compete effectively in federal pharmaceutical procurement markets and has established itself as a critical supplier within the federal pharmaceutical supply chain. The company's robust portfolio with the DLA encompasses an extensive array of medical products ranging from prescription medications and biologics to vaccines and specialty pharmaceuticals, serving military health facilities worldwide. This particular delivery order continues the company's ongoing role in supplying essential pharmaceutical products to support DoD healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FX2AB?
SPE2DB25FX2AB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FX2AB worth?
The government has obligated $20,993 on SPE2DB25FX2AB.
Is contract SPE2DB25FX2AB an order under another contract?
Yes. SPE2DB25FX2AB is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2AB competed?
The extent of competition for SPE2DB25FX2AB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award